Search Results - "Li, JieLang"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Effectiveness of PD-1 inhibitor-based first-line therapy in Chinese patients with metastatic gastric cancer: a retrospective real-world study by Duan, Yichun, Li, Jielang, Zhou, Shuang, Bi, Feng

    Published in Frontiers in immunology (12-06-2024)
    “…Programmed cell death protein-1 (PD-1) inhibitor-based therapy has demonstrated promising results in metastatic gastric cancer (MGC). However, the previous…”
    Get full text
    Journal Article
  2. 2

    Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report by Li, Jielang, Ren, Min, Bi, Feng, Chen, Ye, Li, Zhiping

    Published in Frontiers in immunology (25-08-2023)
    “…Follicular dendritic cell sarcoma (FDCS) is an uncommon low-grade malignant sarcoma. For localized FDCS, surgery is the most commonly recommended therapy…”
    Get full text
    Journal Article
  3. 3

    Casp8 acts through A20 to inhibit PD‐L1 expression: The mechanism and its implication in immunotherapy by Zou, Jiahuan, Xia, Hongwei, Zhang, Chenliang, Xu, Huanji, Tang, Qiulin, Zhu, Gongmin, Li, Jielang, Bi, Feng

    Published in Cancer science (01-07-2021)
    “…Immunotherapy targeting the PD‐L1/PD‐1 pathway is a novel type of clinical cancer treatment, but only small subsets of patients can benefit from it because of…”
    Get full text
    Journal Article
  4. 4

    TLR3 activation efficiency by high or low molecular mass poly I:C by Zhou, Yu, Guo, Ming, Wang, Xu, Li, Jielang, Wang, Yizhong, Ye, Li, Dai, Ming, Zhou, Li, Persidsky, Yuri, Ho, Wenzhe

    Published in Innate immunity (London, England) (01-04-2013)
    “…Toll-like receptor 3 (TLR3) plays a critical role in initiating type I IFN-mediated innate immunity against viral infections. TLR3 recognizes various forms of…”
    Get more information
    Journal Article
  5. 5

    Capecitabine/cisplatin combined with concurrent intensity-modulated radiation therapy: a feasible therapeutic strategy for anal squamous cell carcinoma by Li, Jielang, Huang, Chen, Wang, Xin, Li, Zhiping, Shen, Yali

    Published in Clinical & translational oncology (01-03-2024)
    “…Purpose To evaluate the efficacy and safety of capecitabine/cisplatin (XP) combined with intensity-modulated radiation therapy (IMRT) in patients with…”
    Get full text
    Journal Article
  6. 6

    Cisplatin/capecitabine with intensity-modulated radiation therapy in anal squamous cell carcinoma: a preliminary study by Li, Jielang, Xu, Huanji, Zou, Jiahuan, Wang, Xin, Li, Zhiping, Shen, Yali

    Published in Scandinavian journal of gastroenterology (03-04-2021)
    “…Mitomycin (MMC)/5-fluoroural (5-FU) with concurrent radiation is the standard treatment of anal squamous cell carcinoma (ASCC). The aim of this study is to…”
    Get full text
    Journal Article
  7. 7

    A SwinTransformer-Based Segmentation Framework With Self-Supervised Strategy for Post-Operative Prostate Cancer Radiotherapy by Miao, Dong, Li, Jielang, Dou, Meng, Fu, Linjie, Yao, Yu, Wang, Xin, Wen, Feng, Shen, Yali

    “…Radical prostatectomy (prostate removal) is a standard treatment for clinically localized prostate cancer and is often followed by postoperative radiotherapy…”
    Get full text
    Journal Article
  8. 8

    Efficacy of lenvatinib plus pembrolizumab in hepatocellular carcinoma with metachronous lung metastasis: a report of two cases by Li, JieLang, Chen, Ting, Bi, Feng, Yang, Yu

    Published in Tumori (01-12-2021)
    “…Introduction: Immune checkpoint inhibitors (ICIs) and a combination of ICIs with targeted antiangiogenic agents are effective in treatment of advanced…”
    Get full text
    Journal Article
  9. 9